MedDataX Logo

STREngthening COronavirus Disease 2019 (COVID-19) Surveillance in Africa

NCT ID: NCT06170320

Last Updated: 2023-12-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

7000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-03-01

Study Completion Date

2022-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this observational study was to develop, with the intended users, an epidemic surveillance and response system that will be effective, sensitive, coordinated and appropriate.

The STREESCO project aims to

* Implement active epidemiological surveillance of suspected cases in Benin at strategic sites in accordance with the World Health Organization (WHO) protocol, in support of the national strategy for responding to the CoVID-19 virus.
* To strengthen this national strategy by developing a clinico-epidemiological surveillance system in remote areas of Benin (health centre approach) and Burkina Faso (population survey approach).
* To gain a better understanding of the dynamics of the epidemic and its parameters in Africa thanks to a modern biostatistical and geo-epidemiological analysis of the data collected as part of this project.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Within the framework of the health systems set up by the Benin health authorities, the project aims to develop, with the intended users, an epidemic surveillance and response system that will be effective, sensitive, coordinated and adapted to a context where resources are limited. Following the start of data collection on 01 March 2021, new reforms to the response strategy against CoVID-19 in Benin have led the investigators to opt for a new strategy in order to meet the objectives of the study. The epidemiological surveillance system will be adapted to the reforms, and data collected and processed prospectively on the dynamics of the epidemic will be collected in CoVID-19 screening centres and in public and private health centres. This is the scientific data needed to issue an early warning signal and enable the healthcare system to respond appropriately. The information system will be based on (i) epidemiological surveys in the field, (ii) virological, serological and antigenic tests, (iii) indicators that will enable action to be monitored, adaptation to the epidemic to be assessed and the response capacity of health structures to be controlled. Analysis (biostatistics, geo-epidemiology) of the data collected will provide useful knowledge for a better understanding of the dynamics of the epidemic. Finally, the project will encourage collaboration between African and European researchers and strengthen the capacity of African institutions to set up an epidemic surveillance system.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID-19 SARS CoV 2 Infection COVID-19 Pandemic

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

COVID-19 Epidemiological surveillance Benin strategic sites dynamics

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All volunteering for COVID-19 screening in health units dedicated to COVID-19 activities.
* Having benefited from a COVID-19 test.
* Give free and informed consent to participate in the study.

Exclusion Criteria

* Subjects who did not give free and informed consent to participate in the study.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

European and Developing Countries Clinical Trials Partnership (EDCTP)

OTHER_GOV

Sponsor Role collaborator

Institut de Recherche Clinique du Bénin

UNKNOWN

Sponsor Role collaborator

Barcelona Institute for Global Health

OTHER

Sponsor Role collaborator

Ministère de la Santé - Bénin

UNKNOWN

Sponsor Role collaborator

Ministère de la Santé et de Hygiène Publique - Burkina Faso

UNKNOWN

Sponsor Role collaborator

Institut de Recherche pour le Developpement

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Achille MASSOUGBODJI

Role: PRINCIPAL_INVESTIGATOR

Institut de Recherche Clinique du Bénin

Gilles COTTRELL

Role: STUDY_DIRECTOR

Institut de Recherche pour le Développement - France

Raquel GONZALEZ

Role: STUDY_DIRECTOR

Fundación Privada Instituto de Salud Global Barcelona

Anges YADOULETON

Role: STUDY_CHAIR

Ministère de la Santé - Bénin

Boukary OUEDRAOGO

Role: STUDY_CHAIR

Ministère de la Santé - Burkina Faso

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Institut de Recherche Clinique du Bénin

Abomey-Calavi, Atlantique Department, Benin

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Benin

References

Explore related publications, articles, or registry entries linked to this study.

Atchade A, Yadouleton A, Fiogbe M, Abdoulaye Alfa D, Yovo E, Le Hesran JY, Hounsa S, Bationo C, Figueroa-Romero A, Gaudart J, Gonzalez R, Bonnet E, Massougbodji A, Cottrell G. Determinants of SARS-CoV-2 infection across three sentinels sites in Benin during 2021: A multicentric surveillance study. PLOS Glob Public Health. 2025 Feb 13;5(2):e0004227. doi: 10.1371/journal.pgph.0004227. eCollection 2025.

Reference Type DERIVED
PMID: 39946403 (View on PubMed)

Figueroa-Romero A, Atchade A, Yadouleton A, Fiogbe M, Bonnet E, Yovo E, Accrombessi M, Hounsa S, Paper T, Dupont R, Gaudart J, Le Hesran JY, Massougbodji A, Cottrell G, Gonzalez R. SARS-CoV-2 seroprevalence among Beninese pregnant women in the third year of the pandemic. BMC Public Health. 2024 Jul 2;24(1):1762. doi: 10.1186/s12889-024-19087-4.

Reference Type DERIVED
PMID: 38956517 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RIA2020EF-2923

Identifier Type: -

Identifier Source: org_study_id